Establishment and characterization of a new mantle cell lymphoma cell line, Mino

Leukemia Research

Volumn 26, Issue 9, 2002, Pages 849-855

  Lai, R ^a   McDonnell, T J ^a   O'Connor, S L ^a   Medeiros, L J ^a   Oudat, R ^a   Keating, M ^a   Morgan, M B ^b   Curiel, T J ^b   Ford, R J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

Cell line; Cyclin D1; Mantle cell lymphoma; Mino; p53

Indexed keywords

CD20 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; CYCLIN D1; PROTEIN P16; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; ARTICLE; CELL CYCLE; CELL GROWTH; CELL LINE; CELL LINEAGE; CELL STRUCTURE; CYTOGENETICS; DIPLOIDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; KARYOTYPING; MANTLE CELL LYMPHOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

AMINO ACID SUBSTITUTION; ANEUPLOIDY; ANTIGENS, CD; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL SIZE; CHROMOSOME ABERRATIONS; CODON; CYCLINS; EXONS; FATAL OUTCOME; FEMALE; GENES, P53; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LYMPHOMA, MANTLE-CELL; MIDDLE AGED; MUTATION, MISSENSE; NEOPLASM PROTEINS; POINT MUTATION; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0036065094     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00013-9     Document Type: Article

References (30)

1. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group
2. World Health Organization classification of lymphomas: a work in progress
3. Pathologic diagnosis of mantle cell lymphoma
4. Translocation (11;14): a cytogenetic anormaly associated with B-cell lymphomas of non-follicle center cell lineage
5. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation
6. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma
7. Association of BCL-1 rearrangements with lymphocytic lymphoma of intermediate differentiation
8. Rearrangement of the chromosome 11 BCL-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes
9. Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias
10. PRAD-1/Cyclin D, gene overexpression in chronic lymphoproliferative disorder: a highly specific marker of mantle cell lymphoma
11. Cyclin D1 (bcl-1/PRAD-1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia
12. Expression of Cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of BCL-1/Cyclin D-1 gene
13. Mantle cell lymphoma
14. Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research
15. Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures
16. Proliferative response of mantle cell lymphoma cells stimulated by CD40 ligation and IL-4
17. Mantle cell lymphoma proliferates upon IL-10 in the CD40 system
18. Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia
19. CDKN2B gene in certain B-cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519)
20. Establishment and characterization of a mantle cell lymphoma cell line
21. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS
22. The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigent-negative (SP-53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma
23. Characterization and comparison of two newly established Epstein-Barr virus-negative lymphoma B-cell lines. Surface markers, growth characteristics, cytogenetics, and transplantability
24. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas
25. The Pezcoller lecture: cancer cell cycles revisited
26. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1
27. Cytogenetic findings in mantle cell lymphomas: cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities
28. Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas
29. CD8-positive mantle cell lymphoma: a report of two cases